NCM·Healthcare·$377M·#363 / 520 in Healthcare
SRZN Surrozen, Inc.
32HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY0
STABILITY100
VALUATION0
GOVERNANCE16
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-67.4%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
35 months
99
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-3.5%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
108.4x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-1278
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.1%
25
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+38.5%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE SRZN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when SRZN's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.